Authors: Nagler, RM Gez, E Rubinov, R Laufer, D Ben-Aryeh, H Gaitini, D Filatov, M Kuten, A

Citation: Rm. Nagler et al., The effect of low-dose interleukin-2-based immunotherapy on salivary function and composition in patients with metastatic renal cell carcinoma, ARCH ORAL B, 46(6), 2001, pp. 487-493

Authors: Israel, O Keidar, Z Rubinov, R Iosilevski, G Frenkel, A Kuten, A Betman, L Kolodny, GM Yarnitsky, D Front, D

Citation: O. Israel et al., Quantitative bone single-photon emission computed tomography for prediction of pain relief in metastatic bone disease treated with rhenium-186 etidronate, J CL ONCOL, 18(14), 2000, pp. 2747-2754

Authors: Gez, E Mekori, T Struminger, L Rubinov, R Nativ, O Stein, A Haim, N Kuten, A

Citation: E. Gez et al., T-cell subpopulation in patients with metastatic renal cell carcinoma treated by recombinant interleukin-2, recombinant interferon-alpha, 5-fluorouracil, and vinblastine, CANCER INV, 17(4), 1999, pp. 259-263